文献速递精神分裂症与精神病性障碍

使用患者来源的诱导多能干细胞心肌细胞检查氯氮平诱导的心肌炎中线粒体与炎症小体介导的机制

Examination of mitochondria- and inflammasome-mediated mechanisms of clozapine-induced myocarditis using patient-derived iPSC cardiomyocytes.
PubMed 文献 · Mol Psychiatry · 2025-02-17

研究利用4例耐药性精神分裂症患者(2例有氯氮平诱导的心肌炎史、2例无)来源的诱导多能干细胞分化的心肌细胞,评估线粒体与NLRP3炎症小体介导的机制。2.8 µM氯氮平处理24小时可诱导心功能障碍、细胞毒性、凋亡、氧化应激、线粒体碎片化及炎症因子升高并激活NLRP3炎症小体,这些效应在有心肌炎史者来源的心肌细胞中更明显;靶向线粒体(elamipretide)和炎症小体(ustekinumab)可减轻上述心脏毒性。

要点

  • 2.8 µM氯氮平处理24小时诱导心肌细胞心功能障碍、细胞毒性、凋亡和氧化应激。
  • 氯氮平升高炎症因子并激活NLRP3炎症小体,有心肌炎史者来源细胞效应更明显。
  • elamipretide和ustekinumab可减轻氯氮平诱导的心脏毒性效应。

核心结论

  • 结果提示氯氮平相关心肌炎的发生存在线粒体和NLRP3炎症小体介导的机制,并支持进一步评估靶向线粒体和NLRP3信号的治疗。

研究设计与样本

  • 使用4例耐药性精神分裂症患者(有氯氮平诱导的心肌炎史者2例、无者2例)来源的诱导多能干细胞分化的心肌细胞进行研究。

主要发现

  • 2.8 µM氯氮平处理24小时诱导心肌细胞心功能障碍、细胞毒性增加和凋亡。
  • 2.8 µM氯氮平处理24小时通过升高活性氧水平和线粒体碎片化诱导氧化应激。
  • 2.8 µM氯氮平处理24小时升高促炎细胞因子水平并激活NLRP3炎症小体。
  • 上述效应在有氯氮平诱导的心肌炎史者来源的心肌细胞中更明显。
  • 药理学靶向线粒体(elamipretide)和炎症小体(ustekinumab)可减轻氯氮平诱导的心脏毒性效应。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Clozapine is the only approved pharmacotherapy for treatment-resistant schizophrenia. However, widespread utilization of clozapine is constrained due to the potential for severe adverse effects, including myocarditis. Multiple mechanisms have been suggested to account for the cardiotoxic effects of clozapine, yet these investigations have not used cells derived from clozapine treated patients. In this study, cardiomyocytes that were derived from induced pluripotent stem cells generated from four patients with treatment-resistant schizophrenia with (n = 2) and without (n = 2) a history of clozapine-induced myocarditis were used to assess mitochondria- and NLRP3 inflammasome-mediated mechanisms of this severe adverse drug reaction. We found treatment of cardiomyocytes with a physiologically-relevant dose (2.8 µM) of clozapine for 24 h: (1) induced cardiac dysfunction, increased cytotoxicity, and apoptosis, (2) induced oxidative stress by elevating the level of reactive oxygen species and mitochondrial fragmentation, and (3) elevated levels of proinflammatory cytokines and activated the NLRP3 inflammasome. These effects were more pronounced in cardiomyocytes derived from individuals with a history of clozapine-induced myocarditis. Furthermore, pharmacological targeting of the mitochondria (elamipretide) and inflammasome (ustekinumab) attenuated these clozapine-induced cardiotoxic effects. Collectively, these results suggest a mitochondria- and NLRP3 inflammasome-mediated mechanism in the development of myocarditis associated with clozapine and support further evaluation of therapeutics that target mitochondria and NLRP3 signaling.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Vaziri N, Shutt TE, Karim W, et al. Examination of mitochondria- and inflammasome-mediated mechanisms of clozapine-induced myocarditis using patient-derived iPSC cardiomyocytes. Mol Psychiatry. 2025. PMID: 39962181. doi:10.1038/s41380-025-02935-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。